Novo obesity drug could launch in U.S. end 2014

[riky]

Novo obesity drug could launch in U.S. end 2014

COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential. The world's biggest insulin producer is hoping the treatment for severe obesity will help to at least partly offset the delay to its next generation insulin treatment Tresiba after U.S. regulators asked for more tests. ...

Source: You are not allowed to view links. Register or Login